Sagent Pharmaceuticals Email Format
Pharmaceutical ManufacturingIllinois, United States201-500 Employees
Sagent Pharmaceuticals is a pharmaceutical manufacturing company based in Schaumburg, Illinois, with a workforce of 201 to 500 employees; its website is https://sagentpharma.com. It maintains an extensive product portfolio across diverse therapeutic categories and packaging configurations, including eye drops, vials, syringes, and premix bags. The company has engaged in multiple asset transactions and acquisitions, including acquiring a facility from Xellia Pharmaceuticals in 2019, assets from Athenex Pharmaceutical Division in 2023, and Omega Laboratories in 2014. In 2021, Sagent recalled several lots of levetiracetam injectable seizure medication due to potential sterility issues related to the container closure. Recent developments include a 2023 headcount reduction of 81 at its facility, the 2025 Travoprost Ophthalmic Solution launch, and a 2025 US partnership with Provepharm Sas.